The Data-Centric Lab

The pharmaceutical industry stands at a turning point. While many industries have successfully embraced digital transformation, pharma continues to struggle with outdated systems, fragmented data, and an application-centric mindset that limits progress.

This paper, co-authored by ZONTAL CSO Dennis Della Corte, explores what it truly takes for laboratories to enter the digital age—and why a shift to a data-centric perspective is essential for success.

Why Pharma Has Lagged in Digital Transformation

Despite significant investment in technology, many pharmaceutical organizations still operate within siloed systems that prioritize applications over data. This approach creates barriers to integration, limits scalability, and prevents organizations from fully leveraging their data assets.

The paper highlights that these challenges are not due to a lack of innovation—but rather a fundamental misconception in how data is managed and valued.

To move forward, pharma must shift away from system-centric thinking and toward a model where data itself becomes the foundation of operations.

The Shift to a Data-Centric Lab

A data-centric lab redefines how information flows across the organization. Instead of data being tied to individual applications or instruments, it is structured, standardized, and accessible across systems.

This shift enables greater flexibility, interoperability, and scalability—allowing organizations to adapt more quickly and extract more value from their data.

As the paper outlines, achieving this transformation requires more than incremental change. It demands a rethinking of how data is created, managed, and shared across the entire lifecycle.

The Four Pillars of the Digital Lab

The paper identifies four key criteria that define a post-modern, digitally enabled laboratory. Together, these pillars outline what it takes to successfully transition into the digital age.

Insights Through Advanced Analytics

Modern laboratories must move beyond simple data collection and toward generating actionable insights. Advanced analytics enables organizations to uncover patterns, optimize processes, and accelerate decision-making across R&D.

Machine-to-Machine Communication

Automation is critical for scalability. By enabling systems and instruments to communicate directly with one another, labs can reduce manual intervention, improve efficiency, and ensure consistent data flow across workflows.

Open, Boundaryless Labs

Traditional labs are constrained by organizational and system boundaries. A digital lab removes these barriers, enabling seamless collaboration across teams, partners, and external organizations.

Trust Through Automated Submissions

Regulatory compliance remains a central challenge in pharma. The paper highlights the importance of automated, data-driven submissions that ensure accuracy, traceability, and trust—reducing risk while improving efficiency.

Together, these four pillars define the foundation of a truly digital laboratory environment.

Learning from Other Industries

One of the key insights from the paper is that pharma does not need to start from scratch. Other industries have already undergone digital transformation, providing valuable lessons and proven approaches.

Initiatives such as data-centric architectures, metadata-driven communication, and digital maturity models have enabled organizations in other sectors to unlock significant value from their data.

Applying these same principles to pharma can accelerate transformation—if organizations are willing to rethink their approach.

From Application-Centric to Data-Centric Thinking

At the heart of this transformation is a shift in mindset.

An application-centric approach treats data as a byproduct of systems. A data-centric approach treats data as a strategic asset—one that must be structured, governed, and made accessible across the organization.

This shift enables greater interoperability across systems, improved data quality and consistency, faster integration of new technologies, and a stronger foundation for analytics and innovation.

Without this transition, organizations risk falling behind in an increasingly data-driven industry.

A Foundation for the Future of Drug Development

The move toward data-centricity is not just a technical upgrade—it is a strategic imperative.

By embracing a data-centric model, pharmaceutical organizations can accelerate drug development, improve collaboration, and reduce costs—all while maintaining the trust and compliance required in a highly regulated industry.

As the paper concludes, the organizations that successfully make this transition will be best positioned to thrive in the digital age—delivering faster, better, and more cost-effective outcomes.

Explore the Full Paper

This paper provides a deeper look into the evolution of the data-centric lab, the challenges facing pharmaceutical organizations, and the path forward toward digital transformation.

Read the full paper to understand how a data-centric approach can unlock the full value of scientific data and enable the next generation of pharmaceutical innovation.